x

RSS Newsfeeds

See all RSS Newsfeeds

Global Regions

United States ( XML Feed )

Aug 12, 2016 7:30 EST

Accel Diagnostics, Reader-free blood diagnostic disposable test cards – anytime, anywhere, for everyone

iCrowdNewswire - Aug 12, 2016

Accel 20diagnostics final

Accel Diagnostics

Reader-free blood diagnostic disposable test cards – anytime, anywhere, for everyone.

App shot 3

Company Summary

 

AccelDx is developing, pScreen™, a novel, reader-free, smartphone-enabled blood diagnostic test card. pScreen allows medical care providers and patient consumers to diagnose and monitor of a variety of medical conditions – in the primary care and home settings. The pScreen platform brings total freedom from complex and costly test readers. The entire test fits on a credit-card sized disposable card.

 
  • StagePrototype Ready
  • IndustryMedical Devices and Equipment
  • LocationPittsburgh, PA, US
  • CurrencyUSD
  • FoundedMarch 2012
  • Employees3
  • Websiteacceldx.com

 

Team

  • Alberto is a physicist turned biomedical engineer turned entrepreneur. Alberto founded Accel Diagnostics with the goal of enabling patients the chance to live a better life. Prior to AccelDx, Alberto was Research Professor, University of Houston, and Senior Biomedical Engineer at Carnegie Mellon University. He authored 30 peer-reviewed papers and 4 US patents. His degrees include a Ph.D. in Physics, UH, and a MBA from Carnegie Mellon University.

     

  • Db67c049 bae1 40e7 bbcd 92aed4609e4d
    Head of Engineering

    Joie is a bio-engineer specialized in the field of blood flow, microfluidics and diagnostic systems while completing her postdoctoral work at the National Institute of Standards and Technology (NIST). Not unfamiliar to the challenges of the start-up world, while at Falcon Genomics, Joie developed tools to personalize cancer therapy based on functional genomics. Joie holds a PhD in bioengineering from the University of Pittsburgh.

     

  • 44fc9806 8b70 4dd5 a6e6 cb10271dbbc7
    Test Control Engineer

    Byron is a recent graduate of the University of Pittsburgh with a BS in Biology. Unlike many young scientists/engineer, Byron has decided from the get-go to join the exciting and challenging start-up world. His goal is to bring medical innovation to the masses. Byron’s contributions include the development of the company’s technology, know-how, and relentlessly testing and insuring the quality of our prototypes.

     

  • Default avatar
    Alan Jernigan
    Business Development Advisor
    Unconfirmed

    Alan brings significant expertise in the PoC diagnostic space. Alan is a senior sales and marketing leader with P&L responsibility and an impressive track record for dramatically growing sales rapidly in small, medium and large companies. Strong international and domestic commercialization, strategic planning and execution, product launches, and distributor partner development.

     

  • B225143f b4bd 4fa5 87bf 186ad0d1cb91
    Product Development Advisor

    Steven brings key business and technology leadership. A serial entrepreneur, Steve is the CEO of Proximedics, a medical device company that integrates RFID functionality into healthcare products, and the founding CEO of ClearCount Medical Solutions that developed and commercialized breakthrough RFID sponges to US hospitals. Steve has an MBA from Carnegie Mellon University and a degree in Applied Physics and Bioengineering from Cornell.

     

  • Default avatar
    James F. Antaki
    Technology Advisor
    Unconfirmed

    Dr. Antaki is a Prof. of Biomedical Engineering at Carnegie Mellon. Over the past 25 years, Dr. Antaki has contributed to the development of several medical devices, including the world’s first magnetically levitated axial flow blood pump. He was inducted into AIMBE in 2002, and was the IEEE Controls Systems Technology Award in 2001. He has authored over 150 peer-reviewed papers and holds 16 US patents.

     

  • Default avatar
    David Schwartzman, MD
    Medical Advisor
    Unconfirmed

    Dr. Schwartzman is a Professor of Medicine at the University of Pittsburgh and a member of the UPMC Cardiovascular Institute (CVI). He directs the UPMC Atrial Fibrillation Center as well as the CVI large animal research facility. His expertise and research interests are broad, pertaining to heart and blood vessel-related prevention/reversal, ambulatory monitoring, and minimally invasive surgeries.

     

  • Default avatar
    James McNally
    Advisor
    Unconfirmed
     
 

 

Contact Information:

Alberto Gandini

View Related News >
support